Early Postoperative Compex Rehab NMES Use for Total Knee Arthroplasty Patients
A 12-Month Prospective, Post-Market Study of Early Postoperative Compex® Rehab NMES Use in Total Knee Arthroplasty Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
This study will examine the effects, if any, of using muscle stimulation on the quadriceps following a total knee replacement. Secondary objectives will be to evaluate and compare pain levels, qualitative outcomes, and the impact of NMES on pain medication requests between groups. It is possible that strengthening the quadriceps muscles and improving their activation will reduce postoperative pain and help patients return to activities sooner than with standard therapy alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable knee-osteoarthritis
Started Jan 2013
Longer than P75 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 11, 2013
CompletedFirst Posted
Study publicly available on registry
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2016
CompletedResults Posted
Study results publicly available
April 12, 2021
CompletedApril 12, 2021
April 1, 2021
4 years
January 11, 2013
June 8, 2020
April 6, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Quadriceps Force
Change in quadriceps force is the difference between average quadriceps force measurements (in Newtons) obtained at the 1-year postoperative follow-up minus the average quadriceps force measurement at baseline. Averages are stratified by study arm. Negative values indicate a reduction in quadriceps force from baseline measurement to 1-year.
Baseline and 1-year Follow-up
Secondary Outcomes (1)
Change in VAS Pain Scores
Baseline and 1-year Follow-up
Study Arms (2)
Standard Therapy
NO INTERVENTIONThis arm of the study will follow the standard therapy course after total knee arthroplasty.
Standard Therapy + NMES
EXPERIMENTALThis arm will follow the standard course of therapy but also incorporate daily neuromuscular electrical stimulation into the daily therapy regimen after total knee arthroplasty through use of the Compex Rehab device.
Interventions
Participants in this arm will use a Compex® Rehab unit for neuromuscular electrical stimulation starting with postoperative at-home day 1 and continue using the unit twice a day, every day, until a 10-week follow-up is reached. The unit produces a 380 microsecond biphasic curve and utilizes a four phase process for the treatment ("Warm-up", "Work", "Relaxation", and "Recovery") for a total treatment time of 20 minutes and 5 seconds per session. All frequencies are delivered at the maximum subjective tolerable intensity. Participants will control this intensity and be asked to select a level that is tolerable although mildly uncomfortable; they will be instructed to increase this intensity as tolerated.
Eligibility Criteria
You may qualify if:
- Patient is a candidate for unilateral primary total knee arthroplasty and has a primary diagnosis of osteoarthritis.
- Patient is a male or non-pregnant female age 18 and older at time of surgery.
- Patient has signed an Institutional review board (IRB)-approved, study-specific informed consent form.
- Patient is willing and able to comply with the postoperative scheduled clinical evaluations and rehabilitation.
You may not qualify if:
- Patient has active infection within the affected knee joint.
- Patient requires revision surgery of a previously implanted total knee arthroplasty.
- Patient is morbidly obese, defined as having a body mass index (BMI) greater than or equal to 36.
- Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the intervention.
- Patient has been diagnosed with a systemic disease or current life threatening illness and is not able to carry on normal activities of daily life (e.g. Paget's disease, renal osteodystrophy, etc.).
- Patient has a history of cardiac issues including myocardial infarction and/or has a pacemaker.
- Patient is immunologically suppressed or receiving chronic steroids in excess of 5mg per day.
- Patient has a recent history of substance dependency that may result in deviations from the evaluation schedule.
- Patient is a prisoner.
- Patient has indication for contralateral total knee arthroplasty within the evaluation window.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Orthopaedic Research Foundationlead
- DJO Incorporatedcollaborator
Study Sites (1)
OrthoIndy
Greenwood, Indiana, 46143, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Frank Kolisek
- Organization
- OrthoIndy
Study Officials
- PRINCIPAL INVESTIGATOR
Frank R Kolisek, MD
OrthoIndy South
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2013
First Posted
May 1, 2013
Study Start
January 1, 2013
Primary Completion
December 31, 2016
Study Completion
December 31, 2016
Last Updated
April 12, 2021
Results First Posted
April 12, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share